
Spear Bio Secures $45 Million in Oversubscribed Series A Round to Revolutionize Protein Research and Diagnostics
Spear Bio Inc., an innovative biotechnology company specializing in ultra-sensitive protein detection, has successfully closed an oversubscribed $45 million Series A financing round. The investment was co-led by Foresite Capital and Bio-Techne Corporation, with additional support from Maverick Ventures, Yonjin Capital, and CDH Investments. Vikram Bajaj, Managing Director at Foresite Capital, will join Spear Bio’s…